The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Rohit Jain
Honoraria - Bintaya Foundation; Curio Science; DAVA Oncology; FLASCO; MJH Life Sciences
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; EMD Serono; Exelixis; Gilead Sciences; Johnson & Johnson/Janssen; Lilly; Sanofi
Research Funding - Bristol Myers Squibb; Gilead Sciences; NCI
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation; DAVA Oncology; FLASCO; Sanofi
 
Yuanquan Yang
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - Exelixis; The whiteoak group; Xencor
Speakers' Bureau - AstraZeneca
Research Funding - Amgen (Inst); Incyte (Inst); Novartis (Inst); Recordati (Inst); Xencor (Inst)
 
Laura Graham
Honoraria - DAVA Oncology
Research Funding - Johnson & Johnson/Janssen (Inst); Merck (Inst); Pfizer (Inst)
 
Faustine Ong
No Relationships to Disclose
 
Zhengming Chen
No Relationships to Disclose
 
Bishoy Faltas
No Relationships to Disclose
 
Maria Jiang
No Relationships to Disclose
 
Risa Wong
No Relationships to Disclose
 
Sumati Gupta
Stock and Other Ownership Interests - Salarius Pharmaceuticals (I)
Research Funding - Acrotech Biopharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Daiichi Sankyo/Lilly (Inst); EMD Serono (Inst); Five Prime Therapeutics (Inst); Hoosier Cancer Research Network (Inst); Immunocore (Inst); Incyte (Inst); LSK BioPharma (Inst); MedImmune (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); QED Therapeutics (Inst); Rexahn Pharmaceuticals (Inst); Seagen (Inst); Viralytics (Inst)
(OPTIONAL) Uncompensated Relationships - Astellas Pharma
 
Anishka D’Souza
No Relationships to Disclose
 
Waddah Arafat
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Basilea (Inst); Merck (Inst); Pfizer (Inst); Seattle Genetics/Astellas (Inst)
 
Jazlyn Heiligh
No Relationships to Disclose
 
Timothy Synold
No Relationships to Disclose
 
Scott Tagawa
Stock and Other Ownership Interests - Convergent Therapeutics
Consulting or Advisory Role - 4D Pharma; Abbvie; Abdera Thereapeutics; AIkido Pharma; Ambrx; Amgen; Astellas Pharma; Bayer; Bicycle Therapeutics; Biohaven Pharmaceuticals; Blue Earth Diagnostics; Boston Scientific; Clarity Pharmaceuticals; Clovis Oncology; Convergent Therapeutics; Daiichi Sankyo; Dendreon; Endocyte; Exelixis; Genentech; General Electric; Genomic Health; Gilead Sciences; Hookipa Pharma; Immunomedics; Janssen; Karyopharm Therapeutics; Lantheus Medical Imaging; Lilly; Medivation; Merck; Myovant Sciences; Novartis; Pfizer; POINT Biopharma; QED Therapeutics; Regeneron; Sanofi; Seagen; Telix Pharmaceuticals; Tolmar; TransThera Biosciences
Research Funding - Abbvie (Inst); AIQ Solutions (Inst); Ambrx (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clarity Pharmaceuticals (Inst); Clovis Oncology (Inst); Dendreon (Inst); Endocyte (Inst); Exelixis (Inst); Genentech (Inst); Immunomedics (Inst); Inovio Pharmaceuticals (Inst); Janssen (Inst); Janux Therapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Newlink Genetics (Inst); Novartis (Inst); POINT Biopharma (Inst); Progenics (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst); Stem CentRx (Inst); Telix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Patent Royalty from Immunomedics / Gilead
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; General Electric; Immunomedics; Lantheus Medical Imaging; Merck; Sanofi; Telix Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - ATLAB Pharma; Phosplatin Therapeutics
 
Lorraine Pelosof
No Relationships to Disclose
 
Jingsong Zhang
Consulting or Advisory Role - Dendreon; JNJ; Sanofi; Tolmar
 
Guru Sonpavde
Employment - Exact Sciences (I); Myriad Genetics (I)
Honoraria - Ideology Health; Onviv; PeerView; PrecisCa; UpToDate
Consulting or Advisory Role - Aktis Oncology; Astellas Pharma; Bicycle Therapeutics; Biosite; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Ellipses Pharma; EMD Serono; Exelixis; G1 Therapeutics; Gilead Sciences; GlaxoSmithKline; Janssen; Loxo/Lilly; Loxo/Lilly; Merck; Pfizer; Scholar Rock; Seagen; Syapse; Vial
Speakers' Bureau - Astellas Pharma; AstraZeneca; AVEO; Bayer; Exelixis; Gilead Sciences; Janssen Oncology; Merck; Natera; Pfizer; Research to Practice; Seagen
Research Funding - Bayer (Inst); Blue Earth Diagnostics (Inst); EMD Serono (Inst); Exelixis (Inst); Jazz Pharmaceuticals (Inst); Sumitomo Pharma Oncology (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
Other Relationship - Bristol-Myers Squibb; Elsevier; G1 Therapeutics; Merck; Mereo BioPharma; QED Therapeutics